Previous close | 79.28 |
Open | 79.76 |
Bid | 77.43 x 1300 |
Ask | 85.98 x 900 |
Day's range | 78.26 - 80.78 |
52-week range | 71.59 - 94.20 |
Volume | |
Avg. volume | 1,209,501 |
Market cap | 14.636B |
Beta (5Y monthly) | 0.49 |
PE ratio (TTM) | 2,214.44 |
EPS (TTM) | 0.04 |
Earnings date | 27 Apr 2022 - 02 May 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 116.39 |
Novo Nordisk (NVO) reports better-than-expected results for Q1. Sales are aided by growth in Diabetes and Obesity Care on higher GLP-1 revenues.
Strong demand for sleep and respiratory care devices contributed to ResMed's (RMD) fiscal third-quarter sales performance.
Alnylam's (ALNY) earnings and sales fall shy of estimates in the first quarter of 2022. The company cuts 2022 guidance for net product revenues. Shares down.